Crossmark

A single dose of cajuína does not improve leukocyte count, lipid peroxidation, and physical performance in runners: a randomized, crossover, double‑blind, placebo study

Crossref DOI link: https://doi.org/10.1007/s00394-025-03612-1

Published Online: 2025-02-22

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Solon-Júnior, Luiz José Frota https://orcid.org/0000-0002-5058-2542
de Sousa Fortes, Leonardo https://orcid.org/0000-0002-0778-769X
da Silva Oliveira, José Klinger https://orcid.org/0000-0003-1815-4625
Toscano, Lydiane de Lima Tavares https://orcid.org/0000-0003-0020-6220
da Silva Neto, Luiz Vieira https://orcid.org/0000-0002-1890-3107
License Information

Text and Data Mining valid from 2025-02-22

Version of Record valid from 2025-02-22
More Information

Article History

Received: 18 November 2023

Accepted: 6 February 2025

First Online: 22 February 2025

Declarations

:

: The researcher responsible for the study financed the product, and no company involved in cajuína production provided funding for this research, ensuring no conflict of interest.

Document is current

Any future updates will be listed below